Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Pelthos Therapeutics (PTHS) Revenue (2024 - 2025)

Pelthos Therapeutics has reported Revenue over the past 2 years, most recently at $16.5 million for Q4 2025.

  • Quarterly results put Revenue at $16.5 million for Q4 2025, up 3651.76% from a year ago — trailing twelve months through Dec 2025 was $23.9 million (up 22426.13% YoY), and the annual figure for FY2025 was $16.8 million, changed.
  • Revenue for Q4 2025 was $16.5 million at Pelthos Therapeutics, up from $7.4 million in the prior quarter.
  • Over the last five years, Revenue for PTHS hit a ceiling of $16.5 million in Q4 2025 and a floor of -$464587.0 in Q4 2024.